Clinical Trial Update: Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating the drug-drug interaction of pacritinib with cytochrome P450 substrates and CYP3A4 substrates i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: CTI BioPharma | Conditions: Drug Interactions | Phase 1 | Status: COMPLETED